Organization · Family Office
Hannol Ventures
Hannol Ventures is an investment vehicle focused on healthcare and biotechnology, primarily associated with Dr. Hoyoung Huh. It invests in securities of healthcare companies, often those with which Huh has a direct relationship.
Overview
What Hannol Ventures does
What Hannol Ventures is
Hannol Ventures is an investment vehicle focused on healthcare and biotechnology, primarily associated with Dr. Hoyoung Huh. It invests in securities of healthcare companies, often those with which Huh has a direct relationship.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Hannol Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Hannol Ventures as a funder
Investment thesis
Hannol Ventures invests in healthcare and biotechnology securities, focusing on companies where Dr. Hoyoung Huh has a relationship, particularly in biopharma and therapeutic platforms.
Focus narrative
Hannol Ventures focuses on investments in healthcare technologies, biotechnology, and drug development. The firm seeks opportunities in companies where Dr. Huh has a direct relationship, emphasizing investments that align with his background in biopharma and healthcare innovation.
Value beyond capital
Hannol Ventures adds value through its deep industry connections and expertise in healthcare and biotechnology, particularly in guiding companies through financing and governance challenges. Dr. Huh's background as a biopharma entrepreneur provides portfolio companies with strategic insights and access to a network of industry leaders.
Focus and fit
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include Peak Bio, where Hannol Ventures has held shares following a business combination, and Akari Therapeutics, where Dr. Huh serves as chair. Other associations include Geron Corporation and CytomX Therapeutics, reflecting Dr. Huh's leadership roles in these firms.
Common questions
What to know about Hannol Ventures
Upseed classifies Hannol Ventures under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.